Skip to main navigation

  • About
    • Founders
    • Leadership Team
    • Board of Directors
  • Research and Development
    • Pipeline
    • E3 Ligase Platforms
    • Strategic Partnerships
  • News
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Shareholder Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Culture & Careers
    • Life at Nurix
    • Job Openings
  • Contact

Contact IR

Contact IR

Primary IR Contact

Janhavi Mohite
Stern Investor Relations
IR@nurixtx.com
212-362-1200

 

To request information, please fill out and submit the form below:

Investor Tools

Print Page
Email Alerts
RSS Feeds
Contact IR
© 2020 Nurix Therapeutics, Inc. | Terms of Use |
MENU
  • About
    • Founders
    • Leadership Team
    • Board of Directors
  • Research and Development
    • Pipeline
    • E3 Ligase Platforms
    • Strategic Partnerships
  • News
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Shareholder Resources
      • FAQs
      • Email Alerts
      • Contact IR
      • RSS Feeds
  • Culture & Careers
    • Life at Nurix
    • Job Openings
  • Contact